Zeolite fly ash-enhanced coagulation treatment of oil recovery wastewater from polymer flooding.

Herein, an enhanced coagulation model is proposed in which zeolite is used as a crystal nucleus to promote flocs. The zeolite is prepared from fly ash by microwave-assisted hydrothermal synthesis. Scanning electron microscopy (SEM), X-ray diffraction (XRD), and specific surface area and pore size analysis (BET) characterization confirmed the successful synthesis of ZFA, and improved the surface properties. Thus, the adsorption capacity of ZFA as crystal nucleus was improved, which enabled it to achieve better results in the process of enhanced coagulation. Compared with those of conventional coagulation, the oil content and SS removal rate of ZFA-enhanced coagulation increased by 85% and 44%, respectively. Compared with that of CFA-enhanced coagulation, the oil removal efficiency increased by 4%, and the SS removal efficiency increased by 9%. The optimal conditions of ZFA-enhanced coagulation were as follows: ZFA dosage of 100 mg/L, pH value of 5-8, ZFA particle size range of 60-75 µm, temperature of 40-50 ℃, and precipitation time of 30 min.

Multifactor analysis of patients with oral sensory complaints in a case-control study.

BACKGROUND: There are an increasing number of patients with oral sensory complaints (OSCs) presenting to our dental clinic. For most dentists, it is difficult to distinguish burning mouth syndrome (BMS) from other oral mucosal diseases that may cause symptoms such as burning mouth. It is beneficial to effectively distinguish OSC patients to reduce misdiagnosis and eliminate burning symptoms as much as possible. METHODS: Patients with oral burning sensations in the oral mucosal disease clinic were collected from the Peking University Hospital of Stomatology between September 1, 2014 and December 31, 2018. After excluding oral candidiasis, anemic stomatitis, dental material allergy, and other diseases from patients with oral sensory complaints, basic conditions such as gender, age, education level, job status, hyperglycemia, hypertension, hyperlipidemia, history of brain abnormalities, history of cervical spondylitis, history of thyroid disease, history of thyroid disease and insomnia were obtained. The BMS patients were compared with the control group. The t test and Chi-square test were used for statistical analysis to compare the clinical symptoms of these diseases and explore the risk factors for BMS. RESULTS: In this case-control study, 395 patients (321 females and 74 males, mean age 55.26 ±â€Š10.51 years) with oral sensory complaints and 391 healthy controls (281 females and 110 males, mean age 47.11 ±â€Š13.10 years) were enrolled, among which, 8.4% (33/395) had oral candidiasis, 1.3% (5/395) had dental material allergy, 0.8% (3/395) had anemic stomatitis and 0.5% (2/395) had lichen planus. A total of 352 patients were eventually diagnosed with BMS. Anxiety and depression were more severe in BMS patients, as were the incidences of sleep disorders and brain abnormalities. Logistic regression analysis showed that age (odds ratio [OR] = 2.79, 95% confidence interval [CI]: 1.61-4.83, P < 0.001), total cholesterol level (OR = 2.92, 95% CI: 1.32-6.50, P = 0.009) and anxiety score (OR = 1.75, 95% CI: 1.01-2.77, P = 0.017) significantly increased the incidence of BMS. Patients with hyperglycemia (OR = 0.46, 95% CI: 0.23-0.89, P = 0.022), low body mass index (BMI: OR = 0.57, 95% CI: 0.34-0.93, P = 0.026) and low education level (OR = 3.43, 95% CI: 1.91-6.15, P < 0.001) were more likely to suffer from BMS. CONCLUSIONS: Oral candidiasis, anemic stomatitis, and dental material allergy with burning symptoms should be excluded from patients with BMS. It is recommended to conduct a questionnaire survey (including anxiety and depression), blood cell analysis, and salivary fungus culture for all patients with an oral burning sensation. It is necessary to conduct a patch test on patients with oral burning sensations and metal restorations.